SARC's Open Sarcoma Trials
SARC currently has the following clinical trials open for patient enrollment:
Click on the clinicaltrials.gov study link to read more information such as eligibility criteria and to learn which research centers are actively enrolling patients.
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath Tumor
PI: Brigitte Widemann, MD
SARC012: A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung
PI: Lee J Helman, MD
SARC020: Comparing the efficacy of Trabectedin administered as a 3-hour or 24-hour infusion to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma
PI: James Butrynski, MD and Binh Bui Nguyen, MD, Ph.D.
SARC021: A Randomized Phase III, multicenter, open-label study comparing TH-302 in combination with doxorubicin vs. doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma
PI: William, Tap, MD, Memorial Sloan Kettering Cancer Center
To see where our sites are located, see our map of sites.
www.ClinicalTrials.gov is an online database offering up-to-date information to help patients locate clinical trials for a wide range of diseases and conditions, including sarcoma.
This site is coordinated by the National Institutes of Health and contains close to 50,000 trials that are both federally and privately sponsored and conducted in all fifty states, as well as in many other countries.
The purpose and objectives of the study, eligibility criteria, information about a trial’s sponsor and also a list of institutions participating in the trial, can all be found on a study's website listing on www.ClinicalTrials.gov.